البلد: أيرلندا
اللغة: الإنجليزية
المصدر: HPRA (Health Products Regulatory Authority)
Oxytetracycline hydrochloride
Intervet Ireland Limited
QD06AA03
Oxytetracycline hydrochloride
25 milligram(s)/millilitre
Cutaneous spray, suspension
POM: Prescription Only Medicine as defined in relevant national legislation
Cattle, Pigs, Sheep
oxytetracycline
Antibacterial
Authorised
2009-10-02
1. NAME OF THE VETERINARY MEDICINAL PRODUCT Engemycin Spray, 25 mg/ml, cutaneous spray, suspension for cattle, sheep and pigs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains: ACTIVE SUBSTANCES: 23,15 mg Oxytetracycline equivalent to 25,00 mg Oxytetracycline hydrochloride EXCIPIENTS: QUALITATIVE COMPOSITION OF EXCIPIENTS AND OTHER CONSTITUENTS QUANTITATIVE COMPOSITION IF THAT INFORMATION IS ESSENTIAL FOR PROPER ADMINISTRATION OF THE VETERINARY MEDICINAL PRODUC t _ _ Patent blue V (E131) 1,25 mg Polysorbate 80 Isopropyl alcohol Mixture of hydrocarbons on butane basis (n- butane. isobutane, propane), with denaturant Green to green-blue suspension 3. CLINICAL INFORMATION 3.1 TARGET SPECIES Cattle, sheep and pigs. 3.2 INDICATIONS FOR USE FOR EACH TARGET SPECIES For the treatment of the following infections caused by, or associated with, organisms sensitive to oxytetracycline in cattle, sheep and pigs: Treatment of foot infections caused in particular by: _Dichelobacter nodosus, Fusobacterium _ _necrophorum_ and other _Fusobacterium_ spp., and _Bacteroides _ spp _._ Supporting treatment of superficial wound infections following surgery or physical injuries, e.g., tail biting in pigs, scratches and abrasions. 3.3 CONTRAINDICATIONS Do not use for treatment of teats in order to prevent the veterinary medicinal product from getting into milk. Do not use in cases of hypersensitivity to the active substance or to any of the excipients. 3.4 SPECIAL WARNINGS None. 3.5 SPECIAL PRECAUTIONS FOR USE Special precautions for safe use in the target species: The animals should be treated in a well ventilated area. Do not spray in or near the eyes. Use of the veterinary medicinal product should be based on susceptibility testing of the bacteria isolated from the animal. If this is not possible, therapy should be based on local (regional, farm level) epidemiological information about susceptibility of the target bacteria. Special precautions to be taken by the person administering the veterinary medicinal product to animals اقرأ الوثيقة كاملة